Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Cytoki Pharma ApS
APS
In liquidation
Advertising protection
CVR 40594132
Vandtårnsvej 77, 2860
Søborg
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2019 · 7 years old
3 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Cytoki Pharma ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
-9M
-18M
-28M
-37M
-32M
2021
-99M
2022
-62M
2023
-39M
2024
-42M
2025
EBITDA
DKK millions
0M
-33M
-67M
-100M
-134M
-37M
2021
-107M
-189%
2022
-70M
+35%
2023
-46M
+34%
2024
-49M
-7%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
-31.975
-98.764
-61.548
-39.133
-42.199
Staff expenses
-4.987
-8.079
-8.546
-7.178
-7.262
EBITDA
-36.962
-106.843
-70.094
-46.310
-49.461
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-36.962
-106.843
-70.094
-46.310
-49.461
Net financials
1.413
2.949
75
1.549
161
Profit before tax
-35.549
-103.894
-70.019
-44.762
-49.300
Tax
-5.796
-5.500
-5.500
-5.500
-5.500
Net profit
-29.753
-98.394
-64.519
-39.262
-43.800
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
116.214
68.865
73.927
62.886
17.963
Equity
106.806
51.217
66.697
57.274
13.474
Long-term debt
0
0
0
0
0
Short-term debt
9.408
17.648
7.230
5.612
4.489
Total debt
9.408
17.648
7.230
5.612
4.489
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-4946117300.0%
This company
2021
2025
Equity ratio
75.0%
This company
38.2%
Market median
+96% vs market
2021
2025
Return on equity
-325.1%
This company
18.4%
Market median
-1867% vs market
2021
2025
Net profit margin (of gross profit)
-4380000700.0%
This company
2021
2025
Asset turnover (of gross profit)
-2.35×
This company
2021
2025
Debt / equity
0.33×
This company
0.62×
Market median
+47% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Cytoki Pharma ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
